KRT19 and hepatocellular carcinoma: We also confirmed the expression levels of specific surface markers of CSC of HCC, such as CD133 [34], CD90 [35], CD117 [36], and CK19 [37], which is associated with recurrence, the transition of CSC, and poor survival of HCC.